First human test for kidney disease drug begins
Disease control
Completed
This early-stage study tested the safety and side effects of a single dose of an experimental drug called Gemini in 40 adults with moderate to severe chronic kidney disease. Researchers compared Gemini to a placebo (inactive substance) to see how well it was tolerated and how the…
Phase: PHASE1, PHASE2 • Sponsor: Revelation Biosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC